건강 상태
18 근거 기반 건강기능식품 연구가 있는 건강 상태
Explore health conditions with evidence-graded supplement recommendations. Each condition page ranks ingredients by the strength of clinical research supporting them.
How We Grade Evidence
각 건강 상태 페이지는 임상 근거의 강도에 따라 건강기능식품 성분의 순위를 매깁니다. 각 등급의 의미는 다음과 같습니다:
Strong Evidence
Multiple randomized controlled trials (RCTs) or meta-analyses with consistent positive results and large sample sizes.
Good Evidence
At least one RCT with mostly consistent results across studies. Evidence suggests benefit but more research may be needed.
Some Evidence
Small studies or observational data with some positive signals. Promising but insufficient for strong recommendations.
Very Early Research
In vitro studies, case reports, or pilot studies only. Early-stage research that requires clinical validation.
Acute Bronchitis
5% of adults annually
Allergic Rhinitis
10-30% of adults globally; 40% of children
Gut Immune Health
Gut dysbiosis affects an estimated 25-45% of adults
Post-Viral Fatigue
10-35% of individuals after certain viral infections; ~10% post-COVID
Chronic Inflammation
Estimated 50-60% of adults have at least one inflammatory biomarker elevation
Recurrent Infections
~25% of primary care patients report recurrent infections
Oxidative Stress
Universal physiological process; pathological levels associated with chronic disease
Stress-Related Immune Suppression
Chronic stress affects 70-80% of working adults
Vaccine Response Support
Suboptimal vaccine responses in 30-50% of elderly adults
Pediatric Immune Support
6-8 URTIs per year in children under 6
Exercise-Induced Immune Suppression
Affects endurance athletes and those in heavy training
Sinusitis
31 million episodes annually in the US
Wound Healing and Immune Recovery
50 million surgical procedures annually in the US require immune recovery support
Skin Immune Barrier
Compromised skin barrier affects 15-20% of adults (eczema, dermatitis)
Upper Respiratory Tract Infections
2-4 episodes/year in adults; 6-8 in children
Influenza
5-15% of global population annually
Immune Aging (Immunosenescence)
Affects all individuals with aging; clinically significant after age 65
Autoimmune Conditions
5-8% of the population; >80 recognized autoimmune diseases
FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.